About US
Contact us
-
CFDA Minister Zhang Yong meets Danish Minister of Health and Danish Ambassador to ChinaOn the afternoon of August 28, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), and Jiao Hong, Assistant Minister of CFDA, met with the delegation led by Astrid Krag, Danish Mi2013/9/3
-
China probes of Glaxo, Sanofi, others put big chill on key growth marketIpsen CEO says doctors don't even want to meet with sales reps The big chill is on inChina--at least, that's how Ipsen CEO Marc de Garidel sees it. The recent, and very public, investigation into bri2013/9/2
-
AbbVie, Shire, Pfizer offended by turning Vicodin, Adderall, Xanax into fashion statementJersey-like T's with drug names outrage, but designer insists they are parody AbbVie ($ABBV), Shire ($SHPG) and Pfizer ($PFE) are unamused and unimpressed by a designer's use of the names of their dr2013/9/2
-
J&J follows up on pledge to add warning to Tylenol bottle capsLabel will point out potentially fatal dangers of acetaminophen Acetaminophen, found in more than 600 over-the-counter products like Johnson & Johnson's ($JNJ) popularTylenol, is an effective non2013/8/30
-
Sleepless seniors fuel threefold rise in sleep-drug useAs more and more sleep drugs hit the market, the customer pool is expanding, too. New data from the CDC says prescriptions for sleep drugs have tripled over the last 20 years--with older people record2013/8/30
-
Contract manufacturer Siegfried amps up in China with new plantSwitzerland-based contract manufacturer Siegfried has decided to join the construction line inChinawith a Nantong plant expected to start turning out drug products by mid-2014. Other parts of Siegfrie2013/8/28
-
Bayer's Nexavar in FDA fast lane for thyroid cancer useBayer'sNexavaris one big step closer to athyroid-cancerapproval. The FDA put the drug on the priority-review fast track, which means Nexavar could have its new indication by February. It's a timely wi2013/8/28
-
Fierce welcomes newest publication: FierceDiagnosticsThree years ago, we answered the need for more coverage in the medtech space with the launch ofFierceMedicalDevices. Now one of our top publications, it is proving to be an incredible success. And now2013/8/27
-
Sanofi eyes superiority claim for Fluzone High-Dose after trial boostSanofi's ($SNY) high-dose formulation ofFluzonescored in a new trial in seniors. The study pitted Fluzone High-Dose against the regular formula and found that the amped-up version offered 24% better p2013/8/27
-
Lilly investigating allegations of $4.9M in Chinese bribesEli Lilly ($LLY), the most recent company targeted with bribery accusations inChina, is looking into the matter itself. The company says it is "deeply concerned" by allegations that ran Thursday in a2013/8/26